Lenacapavir: Patient and healthcare provider perceptions and the potential role for a twice‐yearly injectable <scp>HIV</scp> treatment
LA LEN was viewed as a preferable treatment choice for many people with HIV, provided an all-injectable regimen was available. Feasibility assessments for provision of injectable ART and research on its potential for self-administration are needed.
Authors
- Kate Alford
- Jaime H. Vera (ORCID: https://orcid.org/0000-0002-1165-0573)
- Paola Cicconi (ORCID: https://orcid.org/0000-0001-6347-966X)
- Katherine Bristowe (ORCID: https://orcid.org/0000-0003-1809-217X)
- Fiona V Cresswell (ORCID: https://orcid.org/0000-0002-5070-532X)
- Shiraaz Sidat (ORCID: https://orcid.org/0000-0001-6435-3444)
Institutions
- Brighton and Sussex Medical School (GB)
- King's College London (GB)
- Cicely Saunders International (GB)
- Oxford University Hospitals NHS Trust (GB)
- University Hospitals Sussex NHS Foundation Trust (GB)
Publication Details
- Journal
- HIV Medicine
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1111/hiv.13748
- Citations
- 4
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 1.56
Funders
- Gilead Sciences